Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects

Published 2012 View Full Article

Authors

Keywords

Journal

VACCINE

Volume 30, Issue 33, Pages 5030-5037

Publisher

Elsevier BV

Online

2012-04-01

DOI

10.1016/j.vaccine.2012.03.053

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

VACCINE

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Add your recorded webinar